Remission of light chain proximal tubulopathy in IgG λ-type multiple myeloma by lenalidomide and dexamethasone therapy

被引:5
|
作者
Kawamoto, Shinya [1 ]
Hidaka, Yuji [1 ]
Kaneko, Yu [1 ]
Misawa, Hideo [1 ]
Nagahori, Katsuhiro [1 ]
Yoshino, Atsunori [1 ]
Okamura, Takamitsu [2 ]
Ban, Shinichi [3 ]
Ueda, Yoshihiko [3 ]
Takeda, Tetsuro [1 ]
机构
[1] Dokkyo Med Univ, Saitama Med Ctr, Dept Nephrol, 2-1-50 Minamikoshigaya, Saitama 3438555, Japan
[2] Dokkyo Med Univ, Saitama Med Ctr, Dept Internal Med, 2-1-50 Minamikoshigaya, Saitama 3438555, Japan
[3] Dokkyo Med Univ, Saitama Med Ctr, Dept Pathol, 2-1-50 Minamikoshigaya, Saitama 3438555, Japan
关键词
Light chain proximal tubulopathy; Multiple myeloma; IgG lambda M protein; Lenalidomide; SPECTRUM;
D O I
10.1007/s13730-019-00382-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Light chain proximal tubulopathy is a rare manifestation of monoclonal gammopathy. A 73-year-old Japanese woman was noted to have urinary protein and hypertension on health examination and visited the regional clinic. She was noted to have IgG lambda M protein and suspected of multiple myeloma. She was referred to us with massive proteinuria (7.5g/g creatinine) and Bence Jones proteinuria without renal dysfunction. A renal biopsy revealed no glomerular abnormalities, but a tubular cast was observed partially in tubules without tubular atrophy or a crystalline structure. Direct Fast Scarlet staining was absent both in glomerulus and vascular wall. Immunofluorescence revealed lambda light chain (LC) staining in the proximal tubules. Electron microscopy revealed nonspecific findings including increased lysosomes with irregular contours and mottled appearance. A bone marrow biopsy revealed plasma cell proliferation (35%) and multiple myeloma immunoglobulin G lambda type. She showed progressive anemia and decrease of eGFR with elevated level of urinary beta-2 microglobulin. She was treated with lenalidomide+dexamethasone (Ld). With Ld therapy, she achieved hematologic and nephrologic remission reducing the free LC, lambda/kappa ratio, urinary protein level, and urinary beta-2 microglobulin level.
引用
收藏
页码:159 / 165
页数:7
相关论文
共 50 条
  • [21] Light Chain Proximal Tubulopathy of Undetermined Significance
    Ghosh, Toshi
    Leung, Nelson
    Nasr, Samih H.
    Alexander, Mariam P.
    Fidler, Mary E.
    Hernandez, Loren P. Herrera
    Cornell, Lynn D.
    MODERN PATHOLOGY, 2017, 30 : 406A - 407A
  • [22] Light Chain Proximal Tubulopathy of Undetermined Significance
    Ghosh, Toshi
    Leung, Nelson
    Nasr, Samih H.
    Alexander, Mariam P.
    Fidler, Mary E.
    Hernandez, Loren P. Herrera
    Cornell, Lynn D.
    LABORATORY INVESTIGATION, 2017, 97 : 406A - 407A
  • [23] A case of multiple myeloma IgG(λ)type with low molecular weight κ light chain
    Imoto, M
    Ishikawa, K
    Yamamoto, K
    Sinohara, H
    Sakurabayashi, I
    Matsuura, K
    Koyama, A
    Horiuchi, A
    Akiyama, T
    Ohba, Y
    Furuta, I
    CLINICA CHIMICA ACTA, 1998, 277 (01) : 99 - 105
  • [24] Successful outcome of anaplastic multiple myeloma with lenalidomide, cyclophosphamide, and dexamethasone therapy
    Wenjiao Tang
    Yangfan Xu
    Bing Xiang
    Annals of Hematology, 2021, 100 : 3039 - 3040
  • [25] Risk factors for neutropenia with lenalidomide plus dexamethasone therapy for multiple myeloma
    Mitani, Y.
    Usami, E.
    Kimura, M.
    Nakao, T.
    Okada, K.
    Matsuoka, T.
    Kokuryou, T.
    Yoshimura, T.
    Yamakawa, M.
    PHARMAZIE, 2016, 71 (06): : 349 - 351
  • [26] THE EFFICACY OF COMBINATION THERAPY WITH LENALIDOMIDE AND DEXAMETHASONE IN THE TREATMENT OF RELAPSED MULTIPLE MYELOMA
    Szudy-Szczyrek, Aneta
    Legiec, Wojciech
    Manko, Joanna
    Gmyz, Katarzyna
    Szczyrek, Michal
    Hus, Marek
    HEALTH PROBLEMS OF CIVILIZATION, 2015, 9 (02) : 50 - 54
  • [27] Successful outcome of anaplastic multiple myeloma with lenalidomide, cyclophosphamide, and dexamethasone therapy
    Tang, Wenjiao
    Xu, Yangfan
    Xiang, Bing
    ANNALS OF HEMATOLOGY, 2021, 100 (12) : 3039 - 3040
  • [28] Identification and treatment of myeloma cast nephropathy with crystalline light chain proximal tubulopathy induced by Vλ2 light chain
    Wang, Xin
    Yu, Xiao-juan
    Wang, Shuang
    Wang, Su-xia
    Zhou, Fu-de
    Zhao, Ming-hui
    JOURNAL OF NEPHROLOGY, 2025, 38 (01) : 297 - 299
  • [29] Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Moreau, P.
    Masszi, T.
    Grzasko, N.
    Bahlis, N. J.
    Hansson, M.
    Pour, L.
    Sandhu, I.
    Ganly, P.
    Baker, B. W.
    Jackson, S. R.
    Stoppa, A. -M.
    Simpson, D. R.
    Gimsing, P.
    Palumbo, A.
    Garderet, L.
    Cavo, M.
    Kumar, S.
    Touzeau, C.
    Buadi, F. K.
    Laubach, J. P.
    Berg, D. T.
    Lin, J.
    Di Bacco, A.
    Hui, A. -M.
    van de Velde, H.
    Richardson, P. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (17): : 1621 - 1634
  • [30] Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Tan, Carlyn Rose
    Derkach, Andriy
    Nemirovsky, David
    Ciardiello, Amanda
    Diamond, Benjamin
    Hultcrantz, Malin
    Hassoun, Hani
    Mailankody, Sham
    Shah, Urvi
    Maclachlan, Kylee
    Patel, Dhwani
    Lahoud, Oscar B. B.
    Landau, Heather J. J.
    Chung, David J. J.
    Shah, Gunjan L. L.
    Scordo, Michael
    Giralt, Sergio A. A.
    Lesokhin, Alexander
    Usmani, Saad Z. Z.
    Landgren, Ola
    Korde, Neha
    BLOOD CANCER JOURNAL, 2023, 13 (01)